- Centers & Specialties
- Clinical Interests
- Gastrointestinal cancer
- Experimental therapies for GI cancers
- Medical Education
- MD, Columbia University College of Physicians and Surgeons
- Residency, Columbia University Medical Center
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Medical Oncology
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
The Mass General Cancer Center's Dr. David Ryan and Dr. Lecia Sequist were named leaders for two of the four teams.
A record number of participants joined the annual Four Seasons Run of Hope on September 8th to raise awareness for pediatric cancer care and research at MassGeneral Hospital for Children.
The MGH Cancer Center has received a $1.05 million gift from Sovereign Bank, N.A., a division of Santander Holdings USA, in support of its Hematology/Oncology Research Fellowship Fund.
Efforts at Massachusetts General Hospital Cancer Center are underway to address the need for more effective treatment approaches for locally advanced and metastatic disease.
The MGH celebrated the creation of the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research.
On Oct. 12, the Department of Medicine and the Cancer Center announced the appointment of David Ryan, MD, as the new chief of Hematology/Oncology at the MGH. Ryan, who succeeds Jose Baselga, MD, PhD, joined the MGH Cancer Center in 1998.
55 Fruit Street
Boston, MA 02114-2696